467
Views
0
CrossRef citations to date
0
Altmetric
Original Articles: Radiotherapy

Coverage probability planning for simultaneously integrated boosts of inguinal lymph nodes in vulvar cancer

ORCID Icon, , , , &
Pages 1406-1411 | Received 10 Aug 2022, Accepted 02 Oct 2022, Published online: 11 Nov 2022

References

  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.
  • Choi S, Sherertz T. Vulvar cancer. In: Hansen E, Roach III M, editors. Handbook of evidence-based radiation oncology. Cham, Switzerland: Springer; 2018. p. 299–712.
  • Maggino T, Landoni F, Sartori E, et al. Patterns of recurrence in patients with squamous cell carcinoma of the vulva. A multicenter CTF study. Cancer. 2000;89(1):116–122.
  • Stehman FB, Bundy BN, Thomas G, et al. Groin dissection versus groin radiation in carcinoma of the vulva: a gynecologic oncology group study. Int J Radiat Oncol Biol Phys. 1992;24(2):389–396.
  • Petereit DG, Mehta MP, Buchler DA, et al. Inguinofemoral radiation of N0,N1 vulvar cancer may be equivalent to lymphadenectomy if proper radiation technique is used. Int J Radiat Oncol Biol Phys. 1993;27(4):963–967.
  • Dutta S, Coleman RL. Radiation therapy for vulvar carcinoma. 2019. Available from: https://www.glowm.com/section_view/heading/Radiation
  • Oonk MHM, Slomovitz B, Peter JW1, et al. Radiotherapy versus inguinofemoral lymphadenectomy as treatment for vulvar cancer patients with micrometastases in the sentinel node: results of GROINSS-V II. J Clin Oncol. 2021;39(32):3623–3632.
  • Stecklein SR, Frumovitz M, Klopp AH, et al. Effectiveness of definitive radiotherapy for squamous cell carcinoma of the vulva with gross inguinal lymphadenopathy. Gynecol Oncol. 2018;148(3):474–479.
  • Beriwal S, Shukla G, Shinde A, et al. Preoperative intensity modulated radiation therapy and chemotherapy for locally advanced vulvar carcinoma: analysis of pattern of relapse. Int J Radiat Oncol Biol Phys. 2013;85(5):1269–1274.
  • Moore DH, Ali S, Koh WJ, et al. A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: a gynecologic oncology group study. Gynecol Oncol. 2012;124(3):529–533.
  • Natesan D, Hong JC, Foote J, et al. Primary versus preoperative radiation for locally advanced vulvar cancer. Int J Gynecol Cancer. 2017;27(4):794–804.
  • Gaffney DK, King B, Viswanathan AN, et al. Consensus recommendations for radiation therapy contouring and treatment of vulvar carcinoma. Int J Radiat Oncol Biol Phys. 2016;95(4):1191–1200.
  • Rao YJ, Chundury A, Schwarz JK, et al. Intensity modulated radiation therapy for squamous cell carcinoma of the vulva: treatment technique and outcomes. Adv Radiat Oncol. 2017;2(2):148–158.
  • Ramlov A, Assenholt M, Jensen M, et al. Clinical implementation of coverage probability planning for nodal boosting in locally advanced cervical cancer. Radiother Oncol. 2017;123(1):158–163.
  • Lindegaard JC, Assenholt M, Ramlov A, et al. Early clinical outcome of coverage probability based treatment planning for simultaneous integrated boost of nodes in locally advanced cervical cancer. Acta Oncol. 2017;56(11):1479–1486.
  • Pötter R, Tanderup K, Kirisits C, et al. The EMBRACE II study: the outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies. Clin Transl Radiat Oncol. 2018;9:48–60.
  • Baum C, Alber M, Birkner M, et al. Robust treatment planning for intensity modulated radiotherapy of prostate cancer based on coverage probabilities. Radiother Oncol. 2006;78(1):27–35.
  • Mohamed S, Fokdal L, et al. Dosimetric impact of edemal on inguinal lymph node boost in locally advanced vulvar cancer. J Appl Clin Med Phys. 2021;22:315–319.
  • Berger T, Seppenwoolde Y, Pötter R, et al. Importance of technique, target selection, contouring, dose prescription, and dose-planning in external beam radiation therapy for cervical cancer: evolution of practice from EMBRACE-I to II. Int J Radiat Oncol Biol Phys. 2019;104(4):885–894.
  • Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21(1):109–122.
  • Marks LB, Yorke ED, Jackson A, et al. Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys. 2010;76(3):S10–S9.
  • Evans JD, Gomez DR, Amini A, et al. Aortic dose constraints when reirradiating thoracic tumors. Radiother Oncol. 2013;106(3):327–332.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.